In The News

In Bloomberg Law, Silicon Valley Attorneys Analyze Market Trends in Life Sciences Co-Commercialization Deals

Practices: Intellectual Property Transactions, Technology, Media & Telecommunications, Life Sciences Licensing, Collaborations & Joint Ventures, Digital Health, Mergers & Acquisitions, Life Sciences

In a Bloomberg Law article published on Feb. 10, strategic transactions partner Megan Baca and associates Georgina Jones Suzuki and Adam Zuro (all of Silicon Valley) surveyed and analyzed market trends for life sciences co-commercialization arrangements and found that there is a diversity of approaches taken by companies.

With respect to co-commercialization arrangements, the authors examine business rationales, summarize recent market trends, break down deals by financial size and provide negotiation considerations. They conclude that co-commercialization arrangements are valuable tools that allow life science companies to share in the financial risks and rewards associated with the development and commercialization of a drug product. The authors provide various approaches to negotiating co-commercialization terms to effectively close favorable deals.

Cookie Settings